【摘 要】
:
目的:中医治疗恶性肿瘤可提高疗效,减轻化疗的不良反应。中西医结合是我国治疗恶性肿瘤的特色。方法:治疗前均签署知情同意书。两组均采用TPF方案化疗,多西他赛(深圳万乐)7
【机 构】
:
上海上海第九人民医院口腔颌面-头颈肿瘤科
【出 处】
:
第十八届全国临床肿瘤学大会暨2015年CSCO学术年会
论文部分内容阅读
目的:中医治疗恶性肿瘤可提高疗效,减轻化疗的不良反应。中西医结合是我国治疗恶性肿瘤的特色。方法:治疗前均签署知情同意书。两组均采用TPF方案化疗,多西他赛(深圳万乐)75mg/m2,静脉滴注,第1天;DDP(齐鲁制药)75mg/m2,静脉滴注,第1天;5-FU(齐鲁制药)750mg/m2,静脉滴注,第1~5天;每3周重复,共2个周期。
其他文献
Objective: Targeted therapies have considerably improved the prognosis of patients with non-small cell lung cancer (NSCLC).Although not precision enough, RE
目的:为了预估抑制PD-1/PD-L1单抗的单药治疗和/或联合治疗的受益人群,本研究对中国非小细胞肺癌患者进行了一系列肿瘤免疫治疗相关(PD-1,PD-L1和CTLA-4)和肿瘤靶向治疗相
目的: Pemetrexed (P) is the standard of care for non-squamous non-small cell lung cancer (NS NSCLC), whereas epidermal growth factor receptor (EGFR) tyrosine
Objective: To investigate the clinical outcomes and toxicity of stereotactic body radiotherapy (SBRT) with amoderate dose fraction for medically inoperable
Objective: Treatment options for pts with advanced SCC of the lung progressing after platinum-based chemotherapy are limited.Over expression of EGFR, other
Objective: Immunohistochemistry (IHC) and fluorescent in situ hybridization (FISH) are reliable ways to identify over expression of c-Met protein or amplifi
Objective: Nivo, a fully human IgG4 programmed death-1 immune checkpoint inhibitor antibody, has demonstrated durable responses and tolerability in heavily
Objective: The cellular-mesenchymal-epithelial transition protein (MET) has recently been identified as a novel promising target in non-small-cell lung canc
Objective: Amplifications and activating mutations in the c-MET proto-oncogene are known oncogenic drivers that have proven responsive to targeted therapy.
目的:探讨常规超声对甲状腺滤泡病变鉴别诊断的价值。方法:选择2004年至2014年在北京协和医院就诊并被病理证实的59例滤泡癌,以性别、年龄作为匹配条件,随机从病历数据库中选